Functional and Pharmacological Analysis of Cardiomyocytes Differentiated from Human Peripheral Blood Mononuclear-Derived Pluripotent Stem Cells
Dr. Ivor Benjamin and fellow lab research staff have a newly published article for the July 2014 issue of Stem Cell Reports. Advances in induced pluripotent stem cell (iPSC) technology have set the stage for routine derivation of patient- and disease-specific human iPSC-cardiomyocyte (CM) models for preclinical drug screening and personalized medicine approaches. Peripheral blood mononuclear cells (PBMCs) are an advantageous source of somatic cells because they are easily obtained and readily amenable to transduction.
Here, we report that the electrophysiological properties and pharmacological responses of PBMC-derived iPSC-CM are generally similar to those of iPSC-CM derived from other somatic cells, using patch-clamp, calcium transient, and multielectrode array (MEA) analyses. Article Link